Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development. New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board. Seasoned biopharma executive Dr. Neil Johnston has been appointed as Non-Executive Independent Director, effective November 1, 2025.
🌍 Galapagos N.V. (GLPGF) - Form 6-K Filing
Filing Date: 2025-10-30
Accepted: 2025-10-30 16:43:56
Event Type: Executive Changes
Event Details:
💼 Business Developments:
📞 Contact Information: